Agilent Technologies, Inc. with ticker code (A) now have 16 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between $153.00 and $125.00 with the average target price sitting at $137.28. Now with the previous closing price of $131.83 and the analysts are correct then there would likely be a percentage uptick in value of 4.1%. There is a 50 day moving average of $140.34 and the 200 day moving average is $130.03. The company has a market cap of 39.36B. The stock price for the company is currently is currently $134.90 USD
The potential market cap would be $40,985,680,865 based on the market consensus.
The company has a dividend yield of 2.35%. Other points of data to note are a P/E ratio of 31.97, revenue per share of $22.53 and a 7.82% return on assets.
Agilent Technologies, Inc. is engaged in providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics businesses are comprised of six areas of activity, providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its product categories include liquid chromatography systems and components and liquid chromatography mass spectrometry systems.
